Literature DB >> 11164496

Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA preparation.

L R Bisset1, S Bosbach, Z Tomasik, H Lutz, J Schüpbach, J Böni.   

Abstract

The methodological and logistic benefits gained from assessing in vitro antiretroviral replication using one-tube real-time RT-PCR procedures are currently diminished by a continuing need for prior RNA isolation. We now report a simple and inexpensive modification of a commercially available one-tube RT-PCR assay, consisting of detergent-based virus lysis in the presence of a ribonuclease inhibitor, which can be used to directly quantify retroviral RNA levels in culture supernatant. This approach circumvents the potential loss of RNA inherent to RNA-isolation procedures based on prior extraction and demonstrates a dynamic range of at least 4 logs. Using in vitro culture systems incorporating either HIV-1 or FIV, we show that this ability to isolate retroviral RNA directly during the RT-PCR process can provide an equivalent alternative to one of the more time and resource-consuming steps in quantifying in vitro retroviral RNA levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164496     DOI: 10.1016/s0166-0934(00)00259-7

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.

Authors:  Erika Schlaepfer; Annette Audigé; Barbara von Beust; Vania Manolova; Markus Weber; Helene Joller; Martin F Bachmann; Thomas M Kundig; Roberto F Speck
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.

Authors:  Philipp Kaiser; Beda Joos; Barbara Niederöst; Rainer Weber; Huldrych F Günthard; Marek Fischer
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

3.  Artificial 64-Residue HIV-1 Enhancer-Binding Peptide Is a Potent Inhibitor of Viral Replication in HIV-1-Infected Cells.

Authors:  Mouhssin Oufir; Leslie R Bisset; Stefan R K Hoffmann; Gongda Xue; Stephan Klauser; Bianca Bergamaschi; Alain Gervaix; Jürg Böni; Jörg Schüpbach; Bernd Gutte
Journal:  Adv Virol       Date:  2011-09-19

4.  Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.

Authors:  Michael Huber; Marek Fischer; Benjamin Misselwitz; Amapola Manrique; Herbert Kuster; Barbara Niederöst; Rainer Weber; Viktor von Wyl; Huldrych F Günthard; Alexandra Trkola
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

5.  Antiviral Activity of Feline BCA2 Is Mainly Dependent on Its Interference With Proviral Transcription Rather Than Degradation of FIV Gag.

Authors:  Meng Qu; Weiran Wang; Weiting Li; Jiaming Cao; Xin Zhang; Chu Wang; Jiaxin Wu; Bin Yu; Haihong Zhang; Hui Wu; Wei Kong; Xianghui Yu
Journal:  Front Microbiol       Date:  2020-06-11       Impact factor: 5.640

6.  Transcriptional inhibition of feline immunodeficiency virus by alpha-amanitin.

Authors:  Taishi Tanabe; Yurina Fukuda; Kazuhiko Kawashima; Satomi Yamamoto; Takashige Kashimoto; Hisaaki Sato
Journal:  J Vet Med Sci       Date:  2020-11-27       Impact factor: 1.267

7.  Characteristics and Outcome of Patients Diagnosed With HIV at Older Age.

Authors:  Ilan Asher; Keren Mahlab Guri; Daniel Elbirt; Shira Rosenberg Bezalel; Frank Maldarelli; Orna Mor; Zehava Grossman; Zev M Sthoeger
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.